Treatment of respiratory tract diseases and infections with ascorbic acid compositions
US12427180B2 · kind B2 · utility
0Cited by
25References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2023 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Jan 28, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.